Memorial Sloan Kettering Cancer Center: Breast Neoplasms trials

The registry lists 203 Breast Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 42 are open to participants now and 36 have results posted.

Early Phase 1 2Phase 1 35Phase 2 57Phase 3 4Phase 4 4No phase 112(a study in two phases counts in both)

Studies

Page 2 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Acupuncture Pilot Study for Cancer-related Cognitive FunctionActive, not recruitingNCT04007770Phase 2
• Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After TreatmentCompletedNCT03817814
• A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase InhibitorsActive, not recruitingNCT03707340Phase 2
• Assessment of Sensory Gating, Attention, and Executive Control in Breast CancerActive, not recruitingNCT03619083
• Exercise, Fitness and Tumor Profiling in Breast Cancer PatientsActive, not recruitingNCT03424915
• Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast CancerCompletedNCT03377387Phase 1/2
• Development Of A Blood Test To Improve The Performance Of Breast Cancer ScreeningCompletedNCT03372902
• Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain ControlActive, not recruitingNCT03351348Phase 3
• Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast CancerActive, not recruitingNCT03289195Not applicable
• Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast CancerActive, not recruitingNCT03255577Not applicable
• PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerCompletedNCT03166085Phase 1
• Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation TreatmentCompletedNCT02836093
• T-Cell Therapy for Advanced Breast CancerActive, not recruitingNCT02792114Phase 1
• Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast CancerActive, not recruitingNCT02750358Phase 2
• Experience of Arab American Women With Breast Cancer: In-depth InterviewsCompletedNCT02710058
• Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) MetastasesCompletedNCT02650752Phase 1
• Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer SurvivorsCompletedNCT02615054
• Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)Active, not recruitingNCT02605486Phase 1/2
• Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
• Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer PatientsCompletedNCT02364726Not applicable
• Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer ScreeningCompletedNCT02310698
• MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) StudyActive, not recruitingNCT02301767
• Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast CancerCompletedNCT02167854Phase 1
• Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerCompletedNCT02060253Phase 1
• Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After TestingCompletedNCT01992471
• Supervised Aerobic Training During or After Chemotherapy for Operable Breast CancerActive, not recruitingNCT01943695Not applicable
• FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer PatientsCompletedNCT01864083Early Phase 1
• Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their CaregiversCompletedNCT01829984
• QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye LaserCompletedNCT01803516
• Aerobic Training in Metastatic Breast CancerCompletedNCT01725633Not applicable
• Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)CompletedNCT01724606Phase 1
• Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast CancerCompletedNCT01716247Not applicable
• Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast CancerWithdrawnNCT01632956
• Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)TerminatedNCT01532232
• Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development StudyActive, not recruitingNCT01517945
• Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast CancerCompletedNCT01502592Phase 1
• Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer PatientsTerminatedNCT01473680
• Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast CancerCompletedNCT01386411
• Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRIWithdrawnNCT01297231
• GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine TherapyTerminatedNCT01239251
• Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast CancerActive, not recruitingNCT01203839Phase 2
• Lung Inflammation and Lung Metastases From Breast CancerCompletedNCT01182519
• Rehabilitation of Cognitive Changes in Breast Cancer SurvivorsActive, not recruitingNCT01182506Not applicable
• Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without RadiationCompletedNCT01157767
• Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of LifeActive, not recruitingNCT01134172
• International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant RecipientsCompletedNCT01111201
• Digital Mammography for the Detection and Preoperative Staging of Breast CancerCompletedNCT01086514Not applicable
• Genomic Structural Variation in Cancer SusceptibilityActive, not recruitingNCT00996710
• Analysis of Surgery in Patients Presenting With Stage IV Breast CancerCompletedNCT00941759
• Study of Radiation Exposure and Bilateral Breast CancerActive, not recruitingNCT00903591
• Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast CancerCompletedNCT00897702
• Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and AnxietyCompletedNCT00712569
• Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast CancerCompletedNCT00647790
• Expressive Writing and Adjustment to Metastatic Breast CancerCompletedNCT00624156
• Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityCompletedNCT00617370Not applicable
• PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast CancerCompletedNCT00605397Phase 1
• Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled StudyCompletedNCT00597532Not applicable
• An Access Delivery Model That Eliminates Barriers to Breast Cancer Care DeliveryCompletedNCT00597454Not applicable
• Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot StudyCompletedNCT00595062Not applicable
• Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast CancerCompletedNCT00590109
• Menstrual Cycle Maintenance and Quality of Life: A Prospective StudyActive, not recruitingNCT00589654
• The Communication of Genetic Risk to Adolescent Daughters of Women With Breast CancerCompletedNCT00588705
• Quantification of Breast Sensation Following Postmastectomy Breast ReconstructionCompletedNCT00588419
• Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast CancerActive, not recruitingNCT00588029
• Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast CancerCompletedNCT00588003Phase 1
• Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerCompletedNCT00587925Not applicable
• Peptide Profiles of Women Undergoing Breast BiopsyCompletedNCT00587821
• A Survey of Sleep Problems in Survivors of Breast CancerCompletedNCT00587340
• Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast CancerCompletedNCT00582920Phase 1
• Adherence to Intensive Surveillance for Hereditary Breast CancerCompletedNCT00582803
• Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer PatientsActive, not recruitingNCT00582478
• Genetic Studies in Breast CancerCompletedNCT00582322
• Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in SituCompletedNCT00581750
• Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR SpectroscopyCompletedNCT00580086
• Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility EvaluationCompletedNCT00579800Not applicable
• Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
• Clinical Significance of Germline BRCA MutationsActive, not recruitingNCT00579488
• Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
• Breast MRI SpectroscopyCompletedNCT00577915Not applicable
• Cognitive Changes Associated With Breast Cancer TreatmentCompletedNCT00550134
• Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina WomenCompletedNCT00519974
• Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer SurvivorsCompletedNCT00496613
• Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other ConditionsCompletedNCT00471601Not applicable
• Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
• Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and ImmunogenicityActive, not recruitingNCT00393783Phase 1
• Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of DiseaseCompletedNCT00200174Not applicable
• PET Scans in Patients With Locally Advanced Breast CancerCompletedNCT00109785Phase 1
• Acupuncture in Treating Hot Flashes in Women With Breast CancerCompletedNCT00081965Not applicable
• Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous ChemotherapyCompletedNCT00074100Phase 2
• Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00072319Phase 2
• Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to ChemotherapyCompletedNCT00070031Phase 2
• Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate CancerCompletedNCT00059943Phase 2
• Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast CancerCompletedNCT00039286Phase 1
• BMS-247550 in Treating Women With Metastatic Breast CancerCompletedNCT00020904Phase 2
• Celecoxib and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00006381Phase 2
• Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast CancerCompletedNCT00004925Phase 1/2
• Vaccine Therapy in Treating Patients With Breast CancerCompletedNCT00004156Phase 1
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and PaclitaxelCompletedNCT00003540Phase 2
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00003539Phase 2